cbdMD Inc(YCBD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 6 at 4:00 PM ET (Korea 11/7 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.31 | Insider Own | 10.13% | Shs Outstand | 11.1M | Perf Week | 8.7% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 42.42% | Insider Trans | - | Shs Float | 10.1M | Perf Month | 5.37% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.09 | Inst Own | 7.86% | Short Float | 5.42% | Perf Quarter | -26.5% |
| Income | -0.00B | P/S | 0.22 | EPS this Y | 69.72% | Inst Trans | -1.33% | Short Ratio | 1.41 | Perf Half Y | -50.48% |
| Sales | 0.02B | P/B | 0.56 | EPS next 5Y | - | ROA | -25.07% | Short Interest | 0.55M | Perf YTD | -69.19% |
| Book/sh | 0.74 | P/C | 2.2 | EPS past 3/5Y | 86.54% - | ROE | -40.33% | 52W High | -83.75% ($2.56) | Perf Year | -46.67% |
| Cash/sh | 0.19 | P/FCF | - | Sales past 3/5Y | -18.46% -14.45% | ROIC | -28.69% | 52W Low | 26.06% ($0.33) | Perf 3Y | -92.68% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 95.01% | Gross Margin | 52.81% | Volatility(W/M) | 12.19% 9.69% | Perf 5Y | -99.93% |
| Dividend TTM | - | EV/Sales | 0.23 | Sales Y/Y TTM | 10.01% | Oper. Margin | -13.87% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.37 | EPS Q/Q | 46.87% | Profit Margin | -14.71% | RSI (14) | 54.38 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.5 | Sales Q/Q | 20.56% | SMA20 | 10.46% ($0.38) | Beta | 2.31 | Target Price | $2 |
| Payout | - | Debt/Eq | 0.27 | Earnings | 2026/8/13 | SMA50 | -2.93% ($0.43) | Rel Volume | 0.14 | Prev Close | $0.39 |
| Employees | 42 | LT Debt/Eq | 0.23 | EPS/Sales Surpr. | -266.67% -2.38% | SMA200 | -36.36% ($0.66) | Avg Volume(3M) | 0.39M | Price | $0.42 |
| IPO | 2017/11/17 | Option/Short | No/Yes | Trades | 94 | Volume | 54,985 | Change | 7.22% |
Based in Charlotte, North Carolina, this is a cannabidiol (CBD) consumer brand company. It operates multiple brands, including cbdMD, Bluebird Botanicals, Paw CBD for pets, and Oasis THC beverages, and is a small wellness consumer products company that supplies a broad range of offerings—from CBD oils, gummies, capsules, and topicals to Delta-9 THC products.
Over the past 1 year, on the lower side
84% below its 1-year high.
Traded less than usual. That is 14% of its average volume.
YCBD has a sound balance sheet but weak earning power
Of every $100 in sales, $13.87 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +69.7% this year.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $22. Peers typically go for $170.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -99.9%. The S&P 500 did +57% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
VXF Vanguard Extended Market Index ETF <0.01% It ranks #76 of 83 in the industry
Based on market cap of $5M.
FAQ
What kind of company is YCBD?
YCBD belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of YCBD?
The market cap of YCBD is approximately $5M, ranking 5,621 within its sector.
What is the 52-week high and low for YCBD?
YCBD has recorded a 52-week high of $2.56 and a low of $0.33.
